Franck Assayag

1.9k total citations
35 papers, 1.3k citations indexed

About

Franck Assayag is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Franck Assayag has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Franck Assayag's work include Cancer Cells and Metastasis (8 papers), Cancer-related Molecular Pathways (7 papers) and Ocular Oncology and Treatments (5 papers). Franck Assayag is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Cancer-related Molecular Pathways (7 papers) and Ocular Oncology and Treatments (5 papers). Franck Assayag collaborates with scholars based in France, United Kingdom and Switzerland. Franck Assayag's co-authors include Marie‐France Poupon, Elisabetta Marangoni, Patricia de Crémoux, Ludmilla de Plater, Anne Vincent‐Salomon, Didier Decaudin, Charlotte Guyader, Jean‐Gabriel Judde, Olivier Delattre and Nathalie Auger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Franck Assayag

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by Franck Assayag

Since Specialization

Citations

This map shows the geographic impact of Franck Assayag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Assayag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Assayag more than expected).

Fields of papers citing papers by Franck Assayag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Assayag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Assayag. The network helps show where Franck Assayag may publish in the future.

Co-authorship network of co-authors of Franck Assayag

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Assayag. A scholar is included among the top collaborators of Franck Assayag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Assayag. Franck Assayag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two-photon microscopy for microrobotics: Visualization of micro-agents below fixed tissue 2023 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Franck Assayag, Sumit Mohanty, G.R.B.E. Römer, Sarthak Misra	0
2	In vitro bone metastasis dwelling in a 3D bioengineered niche 2020 ·Biomaterials ·Weijing Han, Rania El Botty, Élodie Montaudon, Laurent Malaquin, Frédéric Deschaseaux, Nicolas Espagnolle, Elisabetta Marangoni, Paul Cottu, Gérard Zalcman, Maria Carla Parrini, Franck Assayag, Luc Sensebé, Pascal Silberzan, Anne Vincent‐Salomon, Guillaume Dutertre, Sergio Roman‐Roman, Stéphanie Descroix, Jacques Camonis	25
3	The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers 2018 ·The Journal of Pathology ·(unknown), Franck Assayag, Florian Bonin, Sophie Château‐Joubert, Jean‐Luc Servely, Sophie Vacher, Véronique Becette, Martial Caly, Audrey Rapinat, David Gentien, Pierre de la Grange, Anne Schnitzler, François Lallemand, Elisabetta Marangoni, Ivan Bièche, Céline Callens	53
4	Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease 2018 ·Blood Cells Molecules and Diseases ·Frédéric Pouzoulet, Agustí Alentorn, (unknown), Franck Assayag, Karima Mokhtari, Dalila Labiod, Magali Le Garff‐Tavernier, Maïlys Daniau, Emmanuelle Menet, Matthieu Peyre, Anne Schnitzler, Justine Guégan, Frédéric Davi, Khê Hoang‐Xuan, Carole Soussain	7
5	Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization 2016 ·PLoS ONE ·(unknown), Gérald Massonnet, (unknown), David Gentien, Zofia Maciorowski, Pierre de la Grange, Brigitte Sigal‐Zafrani, Marion Richardson, Sandrine Humbert, Aurélie Thuleau, Franck Assayag, Ludmilla de Plater, Nicolás André, Suzy Scholl, Elisabetta Marangoni, Stefan Weigand, Sergio Roman‐Roman, Ariel Savina, Didier Decaudin	9
6	Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing 2015 ·Ocular Oncology and Pathology ·Nathalie Cassoux, (unknown), Franck Assayag, Isabelle Aerts, Didier Decaudin	7
7	Supersonic Shear Wave Elastography of Response to Anti-cancer Therapy in a Xenograft Tumor Model 2015 ·Ultrasound in Medicine & Biology ·Foucauld Chamming’s, Marie‐Aude Lefrère‐Belda, (unknown), (unknown), Alban Redheuil, Franck Assayag, Laetitia Pidial, Jean‐Luc Gennisson, Mickaël Tanter, C.A. Cuénod, Laure Fournier	16
8	Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts 2014 ·Clinical Cancer Research ·Paul Cottu, Ivan Bièche, Franck Assayag, Rania El Botty, Sophie Château‐Joubert, Aurélie Thuleau, (unknown), Benoît Albaud, Audrey Rapinat, David Gentien, Pierre de la Grange, Vonick Sibut, Sophie Vacher, (unknown), Jean‐Luc Servely, Jean‐Jacques Fontaine, Didier Decaudin, Jean‐Yves Pierga, Sergio Roman‐Roman, Elisabetta Marangoni	42
9	HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts 2014 ·Breast Cancer Research and Treatment ·Patricia de Crémoux, Mathieu Dalvai, (unknown), (unknown), Gaëlle Rolland, (unknown), Franck Assayag, Jacqueline Lehmann‐Che, (unknown), Nicolás André, Brian Lockhart, Elisabetta Marangoni, Hugues de Thé, Stéphane Depil, Kerstin Bystricky, Didier Decaudin	20
10	Abstract 4428: Pre-clinical studies of the therpaeutic effect of a PARP inhibitor combined with radiotherapy for breast cancer treatment. 2013 ·Cancer Research ·Frédéric Pouzoulet, (unknown), (unknown), (unknown), Franck Assayag, Frédérique Mégnin-Chanet, (unknown), Sophie Heinrich, Florence Mahuteau‐Betzer, Aurélie Thuleau, Tomasz Zaremba, Vincent Favaudon, Elisabetta Marangoni, Youlia Kirova, Alain Fourquet, Janet Hall, Didier Decaudin	1
11	Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma 2012 ·Clinical Cancer Research ·Jordan Madic, Sophie Piperno‐Neumann, Vincent Servois, Aurore Rampanou, Maud Milder, Bénédicte Trouiller, David Gentien, (unknown), Franck Assayag, Aurélie Thuleau, Fariba Némati, Didier Decaudin, François‐Clément Bidard, Laurence Desjardins, Pascale Mariani, Olivier Lantz, Marc‐Henri Stern	65
12	Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts 2012 ·Molecular Cancer Therapeutics ·Angela Romanelli, (unknown), Franck Assayag, Sophie Château‐Joubert, Marie‐France Poupon, Jean‐Luc Servely, Jean‐Jacques Fontaine, Xiaohong Liu, E. T. C. Spooner, (unknown), Patricia de Crémoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni	40
13	Molecular profiling of patient-derived breast cancer xenografts 2012 ·Breast Cancer Research ·Fabien Reyal, Charlotte Guyader, Charles Decraene, Carlo Lucchesi, Nathalie Auger, Franck Assayag, Ludmilla de Plater, David Gentien, Marie‐France Poupon, Paul Cottu, Patricia de Crémoux, Pierre Gestraud, Anne Vincent‐Salomon, Jean‐Jacques Fontaine, Sergio Roman‐Roman, Olivier Delattre, Didier Decaudin, Elisabetta Marangoni	140
14	Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts 2011 ·Breast Cancer Research and Treatment ·Paul Cottu, Elisabetta Marangoni, Franck Assayag, Patricia de Crémoux, Anne Vincent‐Salomon, (unknown), Ludmilla de Plater, (unknown), Narjesse Karboul, Jacques Fontaine, Sophie Château‐Joubert, Pascaline Boudou‐Rouquette, S. Alran, Virginie Dangles‐Marie, David Gentien, M F Poupon, Didier Decaudin	60
15	Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation 2010 ·British Journal of Cancer ·Ludmilla de Plater, Anthony Laugé, Charlotte Guyader, M F Poupon, Franck Assayag, Patricia de Crémoux, Anne Vincent‐Salomon, Dominique Stoppa‐Lyonnet, Brigitte Sigal‐Zafrani, Jean‐Jacques Fontaine, Rachel Brough, Christopher J. Lord, Alan Ashworth, Paul Cottu, Didier Decaudin, Elisabetta Marangoni	33
16	A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer 2010 ·Anti-Cancer Drugs ·Ahmed Dahmani, Ludmilla de Plater, Charlotte Guyader, Jean‐Jacques Fontaine, (unknown), Franck Assayag, Philippe Beuzeboc, Elisabetta Marangoni, Fariba Némati, Marie‐France Poupon, (unknown), Stéphane Oudard, Didier Decaudin	2
17	Abstract S6-7: Establishment and Characterization of Human Luminal Breast Cancer Xenografts 2010 ·Cancer Research ·P. Cottu, Franck Assayag, Ludmilla de Plater, (unknown), (unknown), Elisabetta Marangoni, Charlotte Guyader, Pascaline Boudou‐Rouquette, (unknown), David Gentien, Anne Vincent‐Salomon, Fabien Reyal, Patricia de Crémoux, Didier Decaudin	1
18	Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts 2009 ·Anti-Cancer Drugs ·Fariba Némati, Catherine Daniel, Francisco Arvelo, Marie‐Emmanuelle Legrier, (unknown), Alain Livartowski, Franck Assayag, Yveline Bourgeois, Marie‐France Poupon, Didier Decaudin	24
19	Establishment of Human Colon Cancer Cell Lines from Fresh Tumors versus Xenografts: Comparison of Success Rate and Cell Line Features 2007 ·Cancer Research ·Virginie Dangles-Marie, Marc Pocard, Sophie Richon, Louis‐Bastien Weiswald, Franck Assayag, Patrick Saulnier, Jean‐Gabriel Judde, Jean-Louis Janneau, Nathalie Auger, Pierre Validire, Bernard Dutrillaux, Françoise Praz, Dominique Bellet, Marie‐France Poupon	137
20	Grb2‐SH3 ligand inhibits the growth of HER2⁺ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel 2007 ·International Journal of Cancer ·Brunilde Gril, Michel Vidal, Franck Assayag, Marie‐France Poupon, Wang‐Qing Liu, Christiane Garbay	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact